JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1989; 68:249-254
© 1989 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Urquhart, M. L.
Right arrow Articles by White, P. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urquhart, M. L.
Right arrow Articles by White, P. F.

Comparison of Sedative Infusions During Regional Anesthesia—Methohexital, Etomidate, and Midazolam

Murray L. Urquhart, MD, and Paul F. White, PhD, MD

Department of Anesthesia, Stanford University, Stanford, California and the Department of Anesthesiology, Washington University, St. Louis, Missouri.

Abstract

Using a randomized, double-blind study design, the intra-and postoperative sedative effects of three intravenous central nervous system depressants were compared in 64 patients during regional anesthesia. After establishing regional anesthesia, methohexital 59 ± 29 mg IV, etomidate 12.6 ± 8mgIV, or midazolam 3.7 ± 1.5 mg IV (mean dose ± sd) were infused in a titrated fashion over 5–15 minutes to achieve similar end points of sedation. This level of sedation was then maintained with a variable-rate infusion of either methohexital 180 ± 65 mg/hr, etomidate 32 ± 12 mg/hr, or midazolam 7.5 ± 4 mg/hr (mean dose ± SD) To maintain a stable level of sedation, changes in the maintenance infusion rate were required more frequently with methohexital (4.6 ± 3 times) than with etomidate (2.6 ± 2 times) or midazolam (2.7 ± 3 times). Decreases in oxygen saturation below 95% were more frequent with midazolam than with methohexital and etomidate, while recall of intraoperative events was less frequent after midazolam. Observer evaluations found less sedation in the methohexital and etomidate groups than in the midazolam group during the early postoperative period. However, the patients' evaluation of residual sedative effects (e.g., postoperative sedation visual analogue scores) and discharge times from the recovery room were similar in all three groups. Nevertheless, patients given midazolam had significantly greater impairment of performance on the digit-symbol substitution test in the early postoperative period than did patients given either methohexital or etomidate

Key Words: ANESTHETICS, INTRAVENOUS—methohexital, etomidate, midazolam • ANESTHETIC TECHNIQUES, REGIONAL ANESTHESIA—sedation




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
M. M. Sa Rego, Y. Inagaki, and P. F. White
The Cost-Effectiveness of Methohexital Versus Propofol for Sedation During Monitored Anesthesia Care
Anesth. Analg., April 1, 1999; 88(4): 723 - 723.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
M. N. Avramov and P. F. White
Etomidate: Its Pharmacologic and Physiologic Effects
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1997; 1(2): 132 - 141.
[PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 1989 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1989 by the International Anesthesia Research Society.